[ad_1]
(MedPage Today) — Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.
According to data on 1,237 Women’s Health…
[ad_2]
Source link : https://www.medpagetoday.com/infectiousdisease/longcovid/113988
Author :
Publish date : 2025-01-29 05:01:00
Copyright for syndicated content belongs to the linked Source.
Cheap Clinical Biomarker May Predict Long COVID Severity in Older Women
Related Posts
